FDA permits marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome (IBS) when combined with other therapies for IBS.
from FDA Press Releases RSS Feed http://bit.ly/2EXR9tQ
via IFTTT
No comments:
Post a Comment